Renaud Sabatier

Identifiants chercheurs

IdHAL :

renaud-sabatier

ORCID :

0000-0002-5821-682X

IdRef :

148078435

ResearcherID :

http://www.researcherid.com/rid/K-5816-2017

Présentation

Department of Medical Oncology - Institut Paoli-Calmettes

CRCM - Centre de Recherche en Cancérologie de Marseille (Aix-Marseille Univ, CENRS, INSERM, Institut Paoli-Calmettes)

Publications

Article dans une revue (91)

Surgical approach and maintenance therapy in advanced low-grade serous ovarian cancer: Insights from the French ESME database Thomas Papazyan,Elodie Martin,Patricia Pautier,Catherine Guerin-Charbonnel,Elise Rowinskiet al. International Journal of Gynecological Cancer, 2026, 36 (2), pp.102804. ⟨10.1016/j.ijgc.2025.102804⟩ Article dans une revue hal-05527517v1
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand? Arthur Géraud,Paul Gougis,Alexandre de Nonneville,Mathilde Beaufils,François Bertucciet al. Cancer Treatment Reviews, 2025, 135, pp.102922. ⟨10.1016/j.ctrv.2025.102922⟩ Article dans une revue hal-05240065v1
Role of platinum-free interval (PFI) and maintenance therapies in recurrent ovarian cancer to explain survival. An analysis from the French real-world ESME Ovarian Database Claire Chator,Marion Chevrier,Jean-Sébastien Frenel,Frédéric Guyon,Renaud Sabatieret al. Gynecologic Oncology, 2025, 201, pp.17-25. ⟨10.1016/j.ygyno.2025.08.004⟩ Article dans une revue hal-05362636v1
The influence of time and implants in high-dose rate image-guided adaptive brachytherapy for locally advanced cervical cancer Leonel Varela Cagetti,Laurence Gonzague-Casabianca,Marjorie Ferré,Julia Gilhodes,Eric Lambaudieet al. Brachytherapy, 2025, 24 (2), pp.248-257. ⟨10.1016/j.brachy.2024.11.010⟩ Article dans une revue hal-05578032v1
Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy Olivia Le Saux,Renaud Sabatier,Isabelle Treilleux,Léa-Isabelle Renaud,Pierre-Emmanuel Brachetet al. Therapeutic Advances in Medical Oncology, 2025, 17, pp.17588359251347364. ⟨10.1177/17588359251347364⟩ Article dans une revue hal-05223627v1
BTN2A1 acquisition through trogocytosis enhances Vγ9Vδ2 T cell cytotoxicity against autologous and cancer cells Emilien Billon,Caroline Imbert,Damien Bruyat,Pierre Grassi,Lucie Robertet al. Cell Reports, 2025, 44 (10), pp.116387. ⟨10.1016/j.celrep.2025.116387⟩ Article dans une revue hal-05577986v1
PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network Nicolas Rippstein,Christophe Zemmour,Manuel Rodrigues,Isabelle Ray-Coquard,Laurence Gladieffet al. Oncologist, 2025, 30 (5), ⟨10.1093/oncolo/oyaf075⟩ Article dans une revue hal-05180105v1
Practical clinical management of ocular adverse events related to Antibody-Drug Conjugates in gynaecological malignancies Bochra Bouguerra Zina,Frédérique Rousseau,Stephan Fauquier,Renaud Sabatier,Maria Kfoury Cancer Treatment Reviews, 2025, 134, pp.102867. ⟨10.1016/j.ctrv.2024.102867⟩ Article dans une revue hal-05578634v1
The Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Elderly Breast Cancer Patients: What Do We Know? Alexandre Giraudo,Renaud Sabatier,Frederique Rousseau,Alexandre de Nonneville,Anthony Gonçalveset al. Cancers, 2024, 16 (10), pp.1838. ⟨10.3390/cancers16101838⟩ Article dans une revue (article de synthèse) hal-05148479v1
Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25 Coline Montégut,Claire Falandry,Saverio Cinieri,Claire Cropet,Laure Montaneet al. Oncologist, 2024, ⟨10.1093/oncolo/oyae322⟩ Article dans une revue hal-05002859v1
Endometrioid ovarian carcinoma landscape: pathological and molecular characterization Alexandre de Nonneville,Elsa Kalbacher,Francesco Cannone,Arnaud Guille,José Adelaïdeet al. Molecular Oncology, 2024, ⟨10.1002/1878-0261.13679⟩ Article dans une revue hal-04933229v1
Decoding the pathological and genomic profile of epithelial ovarian cancer Rim Rejaibi,Arnaud Guille,Maroua Manai,Jose Adelaide,Emilie Agavnianet al. Scientific Reports, 2024, 14 (1), pp.28573. ⟨10.1038/s41598-024-80030-z⟩ Article dans une revue pasteur-05004059v1
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial Antonio González-Martín,María Jesús Rubio,Florian Heitz,René Depont Christensen,Nicoletta Colomboet al. Journal of Clinical Oncology, 2024, 42 (36), pp.4294-4304. ⟨10.1200/JCO.24.00668⟩ Article dans une revue hal-05033891v1
Deciphering Folate Receptor alphaGene Expression and mRNA Signatures in Ovarian Cancer: Implications for Precision Therapies Maria Kfoury,Pascal Finetti,Emilie Mamessier,François Bertucci,Renaud Sabatier International Journal of Molecular Sciences, 2024, 25 (22), pp.11953. ⟨10.3390/ijms252211953⟩ Article dans une revue hal-04945209v1
Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network Elsa Nigon,Claudia Lefeuvre-Plesse,Alejandra Martinez,Céline Chauleur,Alain Lortholaryet al. Journal of Translational Medicine, 2023, 21 (1), pp.408. ⟨10.1186/s12967-023-04264-7⟩ Article dans une revue hal-04390892v1
Real-world dostarlimab use in advanced/recurrent endometrial cancer in France Manuel Rodrigues,Lauriane Eberst,Philippe Follana,Ludiane Gauthier,Virginie Jacqueminet al. Bulletin du Cancer, 2023, 110 (10), pp.1041-1050. ⟨10.1016/j.bulcan.2023.06.009⟩ Article dans une revue hal-05046854v1
Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort Quentin Dominique Thomas,Amal Boussere,Jean-Marc Classe,Christophe Pomel,Hélène Costazet al. Gynecologic Oncology, 2022, 167 (1), pp.11-21. ⟨10.1016/j.ygyno.2022.08.005⟩ Article dans une revue hal-03868125v1
The safety and efficacy of palbociclib in older patients with advanced breast cancer in a real-world setting Etienne Gouton,Louis Tassy,Joelle Micallef,Amir Meskine,Renaud Sabatieret al. JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8, ⟨10.20517/2394-4722.2022.64⟩ Article dans une revue hal-04085342v1
L’année 2021 dans tous ses états : une synthèse digérée Jacques-Olivier Bay,Carole Bouleuc,Nelly Firmin,Virginie Gandemer,Nicolas Magneet al. Bulletin du Cancer, 2022, 109 (1), pp.8-19. ⟨10.1016/j.bulcan.2021.12.003⟩ Article dans une revue hal-03622801v1
Développement des infirmiers en pratique avancée en oncologie et hémato-oncologie en France : état des lieux précoce Catherine Karine Evans,Renaud Sabatier,Olivier Chinot,Alain Loschi,Sylvie Arnaudet al. Bulletin du Cancer, 2022, 109 (2), pp.139-150. ⟨10.1016/j.bulcan.2021.11.009⟩ Article dans une revue hal-03622825v1
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study Ana Oaknin,Lucy Gilbert,Anna Tinker,Jubilee Brown,Cara Mathewset al. Journal for Immunotherapy of Cancer, 2022, 10 (1), pp.e003777. ⟨10.1136/jitc-2021-003777⟩ Article dans une revue hal-03622811v1
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study Renaud Sabatier,Cécile Vicier,Séverine Garnier,Arnaud Guille,Nadine Carbucciaet al. Molecular Oncology, 2022, 16 (10), pp.2057-2070. ⟨10.1002/1878-0261.13188⟩ Article dans une revue hal-03583253v1
Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network Clémence Romeo,Olivia Le Saux,Margaux Jacobs,Florence Joly,Gwenael Ferronet al. Cancers, 2022, 14 (2), pp.354. ⟨10.3390/cancers14020354⟩ Article dans une revue hal-03622814v1
Actualités 2021 sur le cancer du sein localement avancé ou métastatique RH+/HER2− Essia Mezni,Renaud Sabatier,Anthony Goncalves,Cécile Vicier Bulletin du Cancer, 2022, 109 (2), pp.216-225. ⟨10.1016/j.bulcan.2021.12.009⟩ Article dans une revue hal-03622806v1
Évolution et facteurs associés à la publication des travaux de thèse d’exercice par les internes d’oncologie médicale en France Alexandre de Nonneville,F. Bertucci,Éric Lambaudie,Gilles Houvenaeghel,Renaud Sabatieret al. Bulletin du Cancer, 2022, ⟨10.1016/j.bulcan.2022.01.009⟩ Article dans une revue hal-03623519v1
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial Émilien Billon,Gwenaelle Gravis,Arnaud Guille,Nadine Carbuccia,José Adélaïdeet al. Cancers, 2022, 14 (9), ⟨10.3390/cancers14092275⟩ Article dans une revue hal-04085310v1
Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial Renaud Sabatier,Séverine Garnier,Arnaud Guille,Nadine Carbuccia,Jihane Pakradouniet al. Frontiers in Oncology, 2022, 12, pp.946257. ⟨10.3389/fonc.2022.946257⟩ Article dans une revue hal-04081622v1
Développement des infirmiers en pratique avancée en oncologie et hémato-oncologie en France : état des lieux précoce Catherine Evans,Catherine Karine Evans,Renaud Sabatier,Olivier Chinot,Alain Loschiet al. Bulletin du Cancer, 2022, 109 (2), pp.139-150. ⟨10.1016/j.bulcan.2021.11.009⟩ Article dans une revue hal-03598884v1
Early clinical outcomes of hybrid brachytherapy for locally advanced cervical cancer: making adverse situations in a favorable scenario Leonel Varela Cagetti,Christophe Zemmour,Eric Lambaudie,Magalie Provansal,Renaud Sabatieret al. Journal of Contemporary Brachytherapy, 2022, 14 (4), pp.321 - 331. ⟨10.5114/jcb.2022.118831⟩ Article dans une revue inserm-04053267v1
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial François-Clément Bidard,Anne-Claire Hardy-Bessard,Florence Dalenc,Thomas Bachelot,Jean-Yves Piergaet al. Lancet Oncology, 2022, 23 (11), pp.1367-1377. ⟨10.1016/S1470-2045(22)00555-1⟩ Article dans une revue hal-03867802v1
Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database Alexandre de Nonneville,Christophe Zemmour,Sophie Frank,Florence Joly,Isabelle Ray-Coquardet al. Gynecologic Oncology, 2021, 163 (1), pp.64-71. ⟨10.1016/j.ygyno.2021.07.019⟩ Article dans une revue hal-03622742v1
The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer Leonel Varela Cagetti,Laurence Gonzague-Casabianca,Christophe Zemmour,Eric Lambaudie,Gilles Houvenaeghelet al. Gynecologic Oncology, 2021, 161 (1), pp.166 - 172. ⟨10.1016/j.ygyno.2021.01.034⟩ Article dans une revue inserm-03649584v1
Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer Ana Oaknin,Anna Tinker,Lucy Gilbert,Vanessa Samouëlian,Cara Mathewset al. Future Oncology, 2021, 17 (29), pp.3781-3785. ⟨10.2217/fon-2021-0598⟩ Article dans une revue hal-03622744v1
TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients Cecile Vicier,Patrick Sfumato,Nicolas Isambert,Florence Dalenc,Marie Robertet al. European Journal of Cancer, 2021, 159, pp.205 - 214. ⟨10.1016/j.ejca.2021.09.040⟩ Article dans une revue inserm-03647613v1
Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology Sandrine Rousset-Rouviere,Philippe Rochigneux,Anne-Sophie Chrétien,Stéphane Fattori,Laurent Gorvelet al. Biomedicines, 2021, 9 (6), pp.632. ⟨10.3390/biomedicines9060632⟩ Article dans une revue hal-03622756v1
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial François Bertucci,Anthony Gonçalves,Arnaud Guille,José Adelaïde,Séverine Garnieret al. Genome Medicine, 2021, 13 (1), pp.87. ⟨10.1186/s13073-021-00897-9⟩ Article dans une revue hal-03583277v1
Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer Renaud Sabatier,Johan Martin,Cécile Vicier,Mathilde Guérin,Audrey Monneuret al. Journal of Clinical Medicine, 2021, 10 (6), pp.1272. ⟨10.3390/jcm10061272⟩ Article dans une revue hal-03622759v1
739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged ≥65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial Renaud Sabatier,Cécile Vicier,Séverine Garnier,Arnaud Guille,Nadine Carbucciaet al. Annals of Oncology, 2021, 32 (15_suppl), pp.S737-S738. ⟨10.1016/j.annonc.2021.08.1181⟩ Article dans une revue hal-03622737v1
Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial Renaud Sabatier,Jean-Yves Pierga,Hervé Curé,Rakan Abulnaja,Eric Lambaudieet al. Cancers, 2021, 13 (1), pp.140. ⟨10.3390/cancers13010140⟩ Article dans une revue hal-03622751v1
Circulating tumor DNA as a noninvasive marker of resectability in ovarian carcinomas. Roxane Mari,Christophe Pomel,Pierre-Emmanuel Colombo,Fabrice Narducci,Séverine Garnieret al. Journal of Clinical Oncology, 2021, 39 (15_suppl), pp.5548-5548. ⟨10.1200/JCO.2021.39.15_suppl.5548⟩ Article dans une revue hal-03622754v1
TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients Cecile Vicier,Patrick Sfumato,Nicolas Isambert,Florence Dalenc,Marie Robertet al. European Journal of Cancer, 2021, 159, pp.205-214. ⟨10.1016/j.ejca.2021.09.040⟩ Article dans une revue hal-03622797v1
Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer Ana Oaknin,Anna Tinker,Lucy Gilbert,Vanessa Samouëlian,Cara Mathewset al. Future Oncology, 2021, 17 (29), pp.3781-3785. ⟨10.2217/fon-2021-0598⟩ Article dans une revue hal-03623657v1
Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer Ana Oaknin,Anna Tinker,Lucy Gilbert,Vanessa Samouëlian,Cara Mathewset al. JAMA oncology, 2020, 6 (11), pp.1766. ⟨10.1001/jamaoncol.2020.4515⟩ Article dans une revue hal-03622783v1
Nouvelles AMMs au niveau européen : alpélisib – cancer du sein RH+/HER2− métastatique avec mutation PIK3CA Pauline Corbaux,Renaud Sabatier Bulletin du Cancer, 2020, 107 (10), pp.959-960. ⟨10.1016/j.bulcan.2020.07.007⟩ Article dans une revue hal-03622832v1
New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices? Essia Mezni,Cécile Vicier,Mathilde Guerin,Renaud Sabatier,François Bertucciet al. Cancers, 2020, 12 (6), pp.1573. ⟨10.3390/cancers12061573⟩ Article dans une revue hal-03623669v1
Prediction of early discharge after gynaecological oncology surgery within ERAS Eric Lambaudie,Jérome Mathis,Christophe Zemmour,Camille Jauffret-Fara,Elie Toni Mikhaelet al. Surgical Endoscopy, 2020, 34 (5), pp.1985-1993. ⟨10.1007/s00464-019-06974-w⟩ Article dans une revue inserm-03009273v1
Florilège des actualités oncologiques internationales en 2019 Nicolas Magné,Renaud Sabatier,Marie Wislez,Thierry André,Manuel Rodrigueset al. Bulletin du Cancer, 2020, 107 (2), pp.148-156. ⟨10.1016/j.bulcan.2020.01.010⟩ Article dans une revue hal-02518020v1
High Response to Cetuximab in a Patient With EGFR -Amplified Heavily Pretreated Metastatic Triple-Negative Breast Cancer Renaud Sabatier,Marc Lopez,Arnaud Guille,Emilien Billon,Nadine Carbucciaet al. JCO precision oncology, 2019, 3, pp.1-8. ⟨10.1200/po.18.00310⟩ Article dans une revue hal-03623686v1
Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease Roxane Mari,Emilie Mamessier,Eric Lambaudie,Magali Provansal,Daniel Birnbaumet al. Cancers, 2019, 11 (6), pp.774. ⟨10.3390/cancers11060774⟩ Article dans une revue (article de synthèse) hal-02152656v1
Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease Roxane Mari,Emilie Mamessier,Eric Lambaudie,Magali Provansal,Daniel Birnbaumet al. Cancers, 2019, 11 (6), pp.774. ⟨10.3390/cancers11060774⟩ Article dans une revue hal-03606425v1
Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort Florence Daviet,Franck Rouby,Pascale Poullin,Julie Moussi‐francès,Marion Salléeet al. British Journal of Clinical Pharmacology, 2019, 85 (2), pp.403-412. ⟨10.1111/bcp.13808⟩ Article dans une revue hal-02120988v1
PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences Are Emerging. A Literature Review Gabrielle Planes-Laine,Philippe Rochigneux,François Bertucci,Anne-Sophie Chrétien,Patrice Vienset al. Cancers, 2019, 11 (7), pp.1033. ⟨10.3390/cancers11071033⟩ Article dans une revue (article de synthèse) hal-02533030v1
Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer Renaud Sabatier,Emmanuelle Charafe-Jauffret,Jean-Yves Pierga,Hervé Curé,Eric Lambaudieet al. Journal of Clinical Medicine Research, 2019, 8 (5), pp.612. ⟨10.3390/jcm8050612⟩ Article dans une revue hal-02145624v1
Major Response to Carboplatin in a Patient With Metastatic Triple-Negative Breast Cancer With Somatic Mutation of BRCA1 and Loss of RAD51B Lorène Seguin,Max Chaffanet,Séverine Garnier,José Adélaïde,Nadine Carbucciaet al. JCO precision oncology, 2019, 3, pp.1-9. ⟨10.1200/po.18.00362⟩ Article dans une revue hal-03623688v1
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial D. Moro-Sibilot,N. Cozic,M. Pérol,J. Mazieres,J. Ottoet al. Annals of Oncology, 2019, 30 (12), pp.1985-1991. ⟨10.1093/annonc/mdz407⟩ Article dans une revue hal-02530381v1
RETROSPHER. ERBB2 amplification detection in the plasma at diagnosis for early high-risk HER2-positive breast cancer R. Sabatier,S. Garnier,N. Carbuccia,A. Guille,C. Tarpinet al. Annals of Oncology, 2018, 29 (6), ⟨10.1093/annonc/mdy316.001⟩ Article dans une revue hal-02143655v1
Circulating tumour DNA as an early marker of recurrence and treatment efficacy in ovarian carcinoma, the CIDOC study R. Sabatier,C. Pomel,P-E. Colombo,F. Narducci,S. Garnieret al. Annals of Oncology, 2018, 29 (6), pp.3. ⟨10.1093/annonc/mdy316.007⟩ Article dans une revue hal-02143654v1
Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives? Emanuel Nicolas,François Bertucci,Renaud Sabatier,Anthony Gonçalves Cancers, 2018, 10 (12), pp.506. ⟨10.3390/cancers10120506⟩ Article dans une revue hal-03669695v1
Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer Renaud Sabatier,Véronique Diéras,Xavier B. Pivot,Etienne Brain,Henri Rocheet al. Breast Cancer Research and Treatment, 2018, 50 (4), pp.1226-1237. ⟨10.4143/crt.2017.446⟩ Article dans une revue inserm-01985845v1
A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine L. Seguin,M. Chaffanet,R. Sabatier,A. Jose,S. Garnieret al. Annals of Oncology, 2018, 29 (6), ⟨10.1093/annonc/mdy314.030⟩ Article dans une revue hal-02143656v1
Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer Renaud Sabatier,Emanuel Nicolas,Maria Paciencia,Annie-Pierre Jonville-Bera,Anne Madroszyket al. Journal of Geriatric Oncology, 2018, 9 (5), pp.494-500. ⟨10.1016/j.jgo.2018.02.011⟩ Article dans une revue hal-02143604v1
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer Mathilde Guérin,Anthony Gonçalves,Yves Toiron,Emilie Baudelet,Matthieu Pophillatet al. Oncotarget, 2018, 9 (73), pp.33762-33777. ⟨10.18632/oncotarget.26031⟩ Article dans une revue hal-02145636v1
Determinants of favorable or unfavorable opinion about euthanasia in a sample of French cancer patients receiving palliative care Alexandre de Nonneville,François Bertucci,Pascal Finetti,D. Perrot,M. Nilbertet al. BMC Palliative Care, 2018, 17 (1), pp.104. ⟨10.1186/s12904-018-0357-6⟩ Article dans une revue hal-03583406v1
Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives? Emanuel Nicolas,Francois Bertucci,Renaud Sabatier,Anthony Goncalves Cancers, 2018, 10 (12), ⟨10.3390/cancers10120506⟩ Article dans une revue hal-02143625v1
Safety and efficacy of eribulin for ``real-world'' older patients with metastatic breast cancer Alexandre De Nonneville,Renaud Sabatier,Anthony Goncalves,Jean-Marc Extra,Carole Tarpinet al. Journal of Geriatric Oncology, 2018, 9 (3), pp.281-283. ⟨10.1016/j.jgo.2017.11.003⟩ Article dans une revue hal-02143579v1
[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience]. Laurys Boudin,Christian Chabannon,Patrick Sfumato,Renaud Sabatier,François Bertucciet al. Bulletin du Cancer, 2017, 104 (4), pp.332 - 343. ⟨10.1016/j.bulcan.2016.12.007⟩ Article dans une revue hal-01788977v1
Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study Alexandre de Nonneville,Anthony Gonçalves,Christophe Zemmour,Jean Classe,Monique Cohenet al. Breast Cancer Research and Treatment, 2017, 162 (2), pp.307-316. ⟨10.1007/s10549-017-4136-5⟩ Article dans une revue hal-03623719v1
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer Mathilde Guerin,Keyvan Rezai,Nicolas Isambert,Mario Campone,Aurélie Autretet al. European Journal of Cancer, 2017, 86, pp.28-36. ⟨10.1016/j.ejca.2017.08.025⟩ Article dans une revue istex hal-03623711v1
Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study Laurys Boudin,Anthony Gonçalves,Patrick Sfumato,Renaud Sabatier,François Bertucciet al. American Journal of Cancer, 2016, 7 (14), pp.2077-2084. ⟨10.7150/jca.15797⟩ Article dans une revue inserm-01987531v1
Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study Anthony Gonçalves,François Bertucci,Arnaud Guille,Severine Garnier,José Adelaideet al. Oncotarget, 2016, 7 (48), pp.79428-79441. ⟨10.18632/oncotarget.12714⟩ Article dans une revue hal-03623724v1
Corrigendum to “Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation” [Eur J Cancer 57 (April 2016) 118–126] Laurys Boudin,Christian Chabannon,Patrick Sfumato,Renaud Sabatier,François Bertucciet al. European Journal of Cancer, 2016, 67, pp.223. ⟨10.1016/j.ejca.2016.09.002⟩ Article dans une revue istex hal-03623727v1
Prognostic and predictive value of PDL1 expression in breast cancer Renaud Sabatier,Pascal Finetti,Emilie Mamessier,José Adelaide,Max Chaffanetet al. Oncotarget, 2015, 6 (7), pp.5449-5464. ⟨10.18632/oncotarget.3216⟩ Article dans une revue hal-03583484v1
Stealth&quot; tumors: Breast cancer cells shun NK-cells anti-tumor immunity Emilie Mamessier,François Bertucci,Renaud Sabatier,Daniel Birnbaum,Daniel Olive OncoImmunology, 2014, 1 (3), pp.366-368. ⟨10.4161/onci.18528⟩ Article dans une revue hal-03583489v1
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization Renaud Sabatier,Pascal Finetti,Arnaud Guille,José Adelaïde,Max Chaffanetet al. Molecular Cancer, 2014, 13, pp.228. ⟨10.2174/156652412798376134⟩ Article dans une revue inserm-01192813v1
The CINSARC signature: Prognostic and predictive of response to chemotherapy? François Bertucci,Pascal Finetti,Renaud Sabatier,Daniel Birnbaum Cell Cycle, 2014, 9 (19), pp.4025-4027. ⟨10.4161/cc.9.19.13463⟩ Article dans une revue hal-03623803v1
Personalized medicine: Present and future of breast cancer management Renaud Sabatier,Anthony Gonçalves,François Bertucci Critical Reviews in Oncology/Hematology, 2014, 91 (3), pp.223-233. ⟨10.1016/j.critrevonc.2014.03.002⟩ Article dans une revue hal-03623758v1
Cancer du sein triple-négatif : caractéristiques histocliniques et moléculaires, prise en charge et perspectives thérapeutiques Anthony Gonçalves,Renaud Sabatier,Emmanuelle Charafe-Jauffret,Marine Gilabert,Magali Provansalet al. Bulletin du Cancer, 2013, 100 (5), pp.453-464. ⟨10.1684/bdc.2013.1740⟩ Article dans une revue hal-03623766v1
Breast Metastasis of a Squamous Cell Carcinoma of the Uterine Cervix Mimicking Inflammatory Breast Cancer Renaud Sabatier,Céline Roussin,Jean-Pierre Riviere,Aurélie Jalaguier,Jocelyne Jacquemieret al. Case Reports in Oncology, 2012, 5 (2), pp.464-470. ⟨10.1159/000342255⟩ Article dans une revue hal-03623778v1
Are there candidates for high-dose chemotherapy in ovarian carcinoma? Renaud Sabatier,Anthony Gonçalves,François Bertucci,Maria-Antonietta Capiello,Frédérique Rousseauet al. Journal of Experimental and Clinical Cancer Research, 2012, 31 (1), pp.87. ⟨10.1186/1756-9966-31-87⟩ Article dans une revue inserm-00765646v1
Are we turning to more than a first line treatment of metastatic colorectal cancer with high dose irinotecan?: A monocentric institution safety analysis of 46 patients L. Mineur,R. Sabatier,S. Kirscher,F. Plat,Y. Goubelyet al. Clinics and Research in Hepatology and Gastroenterology, 2011, 35 (2), pp.125-131. ⟨10.1016/j.gcb.2009.11.005⟩ Article dans une revue istex hal-02649856v1
Kinome expression profiling and prognosis of basal breast cancers Renaud Sabatier,Pascal Finetti,Emilie Mamessier,Stéphane Raynaud,Nathalie Cerveraet al. Molecular Cancer, 2011, 10 (1), pp.86. ⟨10.1186/1476-4598-10-86⟩ Article dans une revue hal-03606422v1
Kinome expression profiling and prognosis of basal breast cancers. Renaud Sabatier,Pascal Finetti,Emilie Mamessier,Stéphane Raynaud,Nathalie Cerveraet al. Molecular Cancer, 2011, 10 (1), pp.86. ⟨10.1186/1476-4598-10-86⟩ Article dans une revue inserm-00614833v1
Peritumoural vascular invasion: A major determinant of triple-negative breast cancer outcome Renaud Sabatier,Jocelyne Jacquemier,François Bertucci,Benjamin Esterni,Pascal Finettiet al. European Journal of Cancer, 2011, 47 (10), pp.1537-1545. ⟨10.1016/j.ejca.2011.02.002⟩ Article dans une revue istex hal-03623796v1
A seven-gene prognostic model for platinum-treated ovarian carcinomas R Sabatier,Pascal Finetti,J Bonensea,J Jacquemier,J Adelaideet al. British Journal of Cancer, 2011, 105 (2), pp.304-311. ⟨10.1038/bjc.2011.219⟩ Article dans une revue hal-03637781v1
Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer Renaud Sabatier,Pascal Finetti,José Adelaide,Arnaud Guille,Jean-Paul Borget al. PLoS ONE, 2011, 6 (11), pp.e27656. ⟨10.1371/journal.pone.0027656⟩ Article dans une revue hal-03623789v1
A gene expression signature identifies two prognostic subgroups of basal breast cancer Renaud Sabatier,Pascal Finetti,Nathalie Cervera,Eric Lambaudie,Benjamin Esterniet al. Breast Cancer Research and Treatment, 2010, 126 (2), pp.407-420. ⟨10.1007/s10549-010-0897-9⟩ Article dans une revue hal-00583558v1
Low-grade extraskeletal osteosarcoma of the chest wall: case report and review of literature. Renaud Sabatier,Corinne Bouvier,Gonzague de Pinieux,Anthony Sarran,Isabelle Brenot-Rossiet al. BMC Cancer, 2010, 10, pp.645. ⟨10.1186/1471-2407-10-645⟩ Article dans une revue hal-00546735v1
BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer Renaud Sabatier,José Adélaïde,Pascal Finetti,Anthony Ferrari,Laetitia Huiartet al. Genes, Chromosomes & Cancer, 2010, 49 (12), pp.1143-1151. ⟨10.1002/gcc.20822⟩ Article dans une revue istex hal-03623799v1
Une forme « ariditaire » du cancer de l’ovaire David Birnbaum,Renaud Sabatier,Emilie Mamessier,Daniel Birnbaum,François Bertucci Médecine/Sciences, 2010, 26 (12), pp.1040-1042. ⟨10.1051/medsci/201026121040⟩ Article dans une revue hal-03583491v1
mRNA expression in human breast cancer: a meta-analysis Anthony Gonçalves,Pascal Finetti,Renaud Sabatier,Marine Gilabert,José Adelaïdeet al. Breast Cancer Research and Treatment, 2010, 127 (1), pp.273-281. ⟨10.1007/s10549-010-1199-y⟩ Article dans une revue hal-00594471v1
Gene expression profiling and prediction of clinical outcome in ovarian cancer Renaud Sabatier,Pascal Finetti,Nathalie Cervera,Daniel Birnbaum,François Bertucci Critical Reviews in Oncology/Hematology, 2009, 72 (2), pp.98-109. ⟨10.1016/j.critrevonc.2009.01.007⟩ Article dans une revue istex hal-03623817v1

Pré-publication, Document de travail (1)

Tertiary Lymphoid Structures Are Associated with Enhanced Macrophage Activation and Immune Checkpoint Expression and Predict Outcome in Cervical Cancer Laurent Gorvel,Marylou Panouillot,Marie-Sarah Rouvière,Emilien Billon,Stéphane Fattoriet al. 2026 Pré-publication, Document de travail hal-05123459v1